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Objective: This cross- sectional study aimed to describe cancer- related fatigue (CRF) 
in colorectal cancer (CRC) patients who were surgically treated with curative intent, 
identify subgroups at risk of elevated fatigue levels and explore associations between 
CRF and treatment burden.
Background: CRF is a prominent symptom among cancer patients. In patients treated 
for CRC, CRF is associated with adjuvant treatments, low quality of life and reduced 
ability to self- manage.
Methods: One hundred thirty- four patients with CRC treated at a Norwegian uni-
versity hospital between 2016– 2018 were included. The Schwartz Cancer Fatigue 
Scale- 6 and the Patient Experience with Treatment and Self- management question-
naires were applied for data collection. Statistical analyses included descriptive statis-
tics and non- parametric approaches to analyse correlations and identify differences 
between groups. The study adhered to STROBE Statement checklist for reporting of 
cross- sectional studies.
Results: Median fatigue level was 10.0 (range: 7.0– 13.0). Physical fatigue was higher 
than perceptual fatigue, with medians of 6.0 (interquartile range [IQR]: 3.0– 13.0) 
and 4.0 (IQR: 3.0– 12.0), respectively. Higher fatigue levels were associated with age 
<60 years, advanced cancer and adjuvant treatments. Increased CRF was significantly 
associated with higher treatment burden on seven of the nine dimensions, adjusted 
for demographic and clinical variables. The association of fatigue and treatment bur-
den was stronger in survivors <60 years, with advanced cancer, 6– 12 months since 
surgery or who had more comorbid conditions.
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1  |  INTRODUC TION
Cancer- related fatigue (CRF) is a common symptom in cancer sur-
vivors. Compared with a healthy population, cancer survivors are 
often more fatigued, and fatigue can occur for years following pri-
mary treatment (Husson et al., 2015). Colorectal cancer (CRC) is 
one of the most commonly occurring cancers, with over 1.8 million 
new cases in 2018 (Ferlay et al., 2019). In Norway, 4332 new CRC 
cases were registered in 2017 (Cancer Registry in Norway, 2017), 
the world's fourth largest incidence rate (Ferlay et al., 2019). Fatigue 
is one of the most severe symptoms following treatment in CRC sur-
vivors (Han et al., 2020). High levels of CRF in CRC survivors have 
been associated with chemotherapy treatment, low quality of life 
(QoL) and a reduced ability to self- manage (Vardy et al., 2016).
Surgical tumour resection is a cornerstone of the primary treat-
ment of CRC patients with non- metastatic disease. Although ad-
juvant chemotherapy is generally recommended in colon cancer 
patients with lymph node metastases (i.e., Dukes Stage C), neoad-
juvant chemo- radiation treatment is only selectively employed ac-
cording to given criteria in rectal cancer patients (Lewis & Espat, 
2016). As a result of the enhanced recovery approach, CRC patients 
now spend less time in hospital following primary surgery (Zhuang 
et al., 2013). Recent reports indicate that CRC patients often feel un-
prepared for the period that follows after hospital treatment, expe-
riencing increased and sometimes overwhelming self- management 
demands related to altered bowel function, bladder complications, 
sexual dysfunction, ostomy- related complications and fatigue 
(Lubberding et al. 2015). A large self- management workload may re-
sult in treatment burden, defined as ‘the impact of health care on pa-
tients' functioning and well- being’ (Eton et al., 2012), and described 
as the extra work created through self- care and self- monitoring, the 
management of therapeutic regimens, organising doctors' visits and 
managing transitions from hospital to home, as delegated to chron-
ically ill patients by health professionals.
Additionally, reflecting the large proportion of CRC patients 
who are older (>70 years), many may suffer from other chronic de-
bilitating conditions (Boakye et al., 2018); thus, CRC patients may 
experience treatment burden. Comorbidity, such as cardiovascular 
disorders and lung diseases, are also associated with higher risk 
of post- operative complications in CRC patients >70 years of age, 
which may complicate recovery outcomes (Flynn et al., 2020). In a 
cohort study of 1017 CRC patients, one third of the patients had not 
returned to pre- surgical QoL levels after 5 years, and comorbidity 
of two or more chronic illnesses was associated with deceased QoL 
(Wheelwright et al., 2020). In a recent study among the same patient 
cohort as the current study, CRC patients reported treatment bur-
den across several dimensions, including difficulties in accessing and 
understanding medical information, attending to medical appoint-
ments and monitoring their health condition and health behaviour, 
all of which affected their well- being (Husebø et al., 2021).
CRF adds to treatment burden by decreasing a patient's ability 
to perform daily life activities and self- care tasks, negatively impact-
ing interpersonal relationships and interfering with social life roles 
(Jones et al., 2016). As yet, there is no empirical evidence to help 
clarify the reciprocal relationship between CRF and treatment bur-
den, and gaining a broader perspective of CRC patients' experiences 
of treatment and self- management tasks is important. This study 
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Conclusions: This study showed patients at risk of experiencing CRF following CRC 
treatment. It established proof of associations between CRF and treatment burden 
and identified subgroups of CRC patients where this association was stronger.
Relevance to clinical practice: Screening of CRF in CRC patients can help clinicians 
provide individualized treatment and care to manage CRF. Clinicians should consider 
the association between CRF and treatment burden, especially in subgroups of CRF 
patients.
K E Y W O R D S
cancer- related fatigue, colorectal cancer, cross- sectional survey, self- management, treatment 
burden
What does this paper contribute to the wider 
global community?
• This study demonstrated that cancer- related fatigue 
(CRF) is a problem to patients surgically treated for 
colorectal cancer (CRC) and identified younger patients, 
advanced cancer and adjuvant treatments as risk factors 
for experiencing CRF.
• CRF and treatment burden are positively and signifi-
cantly related concepts.
• The study identified subgroups of CRC patients with a 
stronger association between CRF and workload dimen-
sions of treatment burden.
• The CRC clinical pathway may include screening of 
patients' CRF and treatment burden levels and be ex-
tended by providing nurse- led informational, educa-
tional and psychosocial support post- hospital discharge 
to ameliorate CRF and treatment burden.
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investigated the incidence and characteristics of CRF in a CRC pa-
tient sample and examined the associations between CRF and treat-
ment burden.
2  |  BACKGROUND
CRF is defined as ‘a distressing persistent, subjective sense of physi-
cal, emotional and cognitive tiredness related to cancer or cancer 
treatment that is not proportional to recent activity and interferes 
with usual functioning’ (Berger et al., 2015). The CRF experience is 
usually captured by the use of patient- reported outcome measures 
(PROMs), and a large number of PROMs for CRF exist (Nordin et al., 
2016). Compared with a healthy population, CRC survivors experi-
ence significantly more fatigue; in particular, short- term survivors 
(<5 years post- diagnosis) report substantially higher fatigue levels 
(Thong et al., 2013). In a recent systematic review and meta- analysis 
of the symptom experience in CRC survivors, compared with older 
patients, younger patient age and younger age at diagnosis were 
not found to be risk factors of fatigue (Han et al., 2020). Regarding 
differences between genders, female CRC patients have reported 
significantly higher CRF levels than male patients (Aminisani et al., 
2017; Husson et al., 2015). These studies also found that comorbid-
ity was associated with elevated CRF levels.
Patients with CRC must deal with many dimensions of treatment 
burden during their treatment trajectory and must balance demands 
with their capacity to self- manage (Husebø et al., 2021). The pre-
dominant consequences of treatment burden in patients suffering 
from long- term illness are impaired health and well- being (Eton et al., 
2019; Lippiett et al., 2019), non- adherence to treatment and lifestyle 
interventions (May et al., 2014; Schreiner et al., 2020), costly read-
missions (Eton et al., 2012) and burden on significant others (Sav 
et al., 2013). The literature on treatment burden in cancer popula-
tions is limited, and only two original studies have been conducted 
(Eton et al., 2019; Anderson et al. 2021). Eton et al. (2019) explored 
the impact of perceived treatment and self- management burden in 
91 multimorbid cancer patients and found that treatment burden 
harmed health- related QoL. The study did not investigate the burden 
from generic self- management work (i.e., monitoring health, attend-
ing medical appointments and navigating problems with healthcare 
services). In Anderson et al. (2021), female cancer survivors reported 
that the impact of self- management negatively affected their general 
health, an association more prominent in single, multimorbid individ-
uals, low on health literacy and who worked full time. A systematic 
review described treatment burden in patients with lung cancer as 
managing treatment side effects, burdensome cognitive decision- 
making processes and dealing with multiple treatment appointments, 
among others (Lippiett et al., 2019). The authors concluded that a 
clear treatment pathway with rapid access to healthcare services 
might reduce the post- diagnosis treatment burden.
On the basis of recent studies showing that CRF is signifi-
cantly associated with increased impairment of performing 
life tasks, including self- care (Jones et al., 2016), we aimed to 
describe CRF and explored the relationship between CRF and 
treatment burden in CRC patients treated with curative intent. 
This exploration was accomplished through the following re-
search questions:
Research Question 1: What is the level of CRF in CRC patients 
treated with curative intent at a Norwegian university hospital?
Research Question 2: How does the level of CRF vary according 
to demographic and clinical variables?
Research Question 3: What are the associations between CRF 
and the different dimensions of treatment burden in this study 
population, and are they moderated by socio- demographic and 
clinical variables?
3  |  METHODS
3.1  |  Study design and setting
The study applied a retrospective cross- sectional design and took 
place in a university hospital in the south- western part of Norway 
in 2017– 2018. The Department of Gastrointestinal Surgery offers 
acute and elective surgical service, and annually, more than 300 
CRC patients undergo surgery at the facility. Ethical approval was 
obtained from the Regional Committee for Medical and Health 
Research Ethics and from the data protection officer at the hospi-
tal where the participants were recruited. All participants provided 
informed written consent and were guaranteed confidentiality and 
the right to withdraw from the study at any time. The patients also 
gave their permission to use their data obtained from the hospi-
tal's medical records. The study adheres to the Strengthening the 
Reporting of Observational Studies in Epidemiology (STROBE) 
guideline for cohort, case– control and cross- sectional studies 
(Appendix S1).
3.2  |  Study population
The study sample was drawn from the electronic hospital records 
of individuals treated for CRC with curative intent in 2016– 2018. 
The inclusion criteria were as follows: between 18– 80 years of age, 
surgically treated for either colon or rectal cancer with curative in-
tent, no distant metastases (i.e., Dukes Stages A– C; Labianca et al., 
2010; National Institute for Health and Clinical Excellence (Great 
Britain), 2014), an elapsed time since primary surgery of 2 months to 
2 years and able to speak and write Norwegian. The exclusion crite-
ria were as follows: metastatic cancer, severe post- operative surgi-
cal complications (i.e., grade >3 according to Clavien– Dindo Surgical 
Complications Score; Clavien et al., 2009) or mental illness or cogni-
tive impairment. The main reasons for non- eligibility were old age 
(>80 years) or metastatic cancer.
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3.3  |  Data collection
Two different recruitment procedures were used: (a) a request con-
taining an information letter, consent form and the survey inventory 
was mailed to patients who were surgically treated between June 
2016– September 2017, and (b) a study nurse recruited patients who 
were surgically treated between October 2017– June 2018 at their 
first post- operative outpatient follow- up appointment. Patients 
recruited at the outpatient clinic received written information, the 
consent form and the survey inventory and were educated by the 
study nurse on how to fill in the forms at home. One reminder let-
ter was mailed to all non- responders 2 weeks following the time of 
recruiting. The participants did not receive any compensation for 
participation.
Clinical data (diagnosis, cancer stage, treatment modes, surgical 
complication category and number of comorbidities) were collected 
from the electronic hospital records. A questionnaire for collect-
ing demographic and clinical characteristics was developed for this 
study, including items on age, gender, ethnicity, marital status, living 
conditions, education and employment.
3.4  |  Measures
3.4.1  |  Schwartz Cancer Fatigue Scale- 6
The Schwartz Cancer Fatigue Scale- 6 (SCFS- 6) developed by 
Schwartz and Meek (1999) is a scale of six items measuring CRF 
on two dimensions: physical (i.e., worn out, tired and listless) and 
perceptual (i.e., difficulties thinking, overcome and helpless). The 
physical dimension is related to a decline in physical functioning, 
and the perceptual dimension assesses changes in mood state that 
may affect the patient's preparedness to take action (Schwartz 
et al., 2003). The scale instructions stated: ‘The words and phrases 
below describe different emotions that can be associated with 
exhaustion. Please read through them and put a ring around the 
number that corresponds to how much these feelings have af-
fected you in the last 2– 3 days’.
The items are scored on a Likert scale of 1 (not at all) to 5 (ex-
tremely). The summed score ranges from 6– 30, where higher 
scores indicate more fatigue. The Norwegian version of the SCFS- 6 
has demonstrated a Cronbach's α of 0.83 in a cancer population 
(Husebø et al., 2014). In the current study, the instrument obtained 
a Cronbach's α of 0.91.
3.4.2  |  Patient Experience with Treatment and Self- 
management
Treatment burden was measured by the Norwegian version of the 
Patient Experience with Treatment and Self- management (PETS) 
questionnaire. PETS is a self- report measure of treatment burden 
for patients with chronic conditions (Eton et al., 2017). The original 
PETS was translated and adapted for use in a Norwegian healthcare 
context by Husebø et al. (2018). The Norwegian version contains 
nine dimensions and 48 items. The first four dimensions— medical 
information (MINF; seven items), medications (MEDS; seven items), 
medical appointments (MAP; six items) and monitoring health 
(MH; two items)— pertain to the workload of self- management (Lee 
et al., 2020). The following three dimensions— relationship with 
others (RLO; four items), medical and healthcare expenses (MEXP; 
four items) and difficulties with healthcare services (HCS; seven 
items)— relate to stressors aggravating burden, whereas the last two 
dimensions— the role and social activity limitations (RAL; six items) 
and physical and mental fatigue from self- management (PMF; five 
items)— pertain to the impact of burden (Lee et al., 2020). Responses 
were provided using either a 4- or a 5- point Likert scale. The recall 
time was 4 weeks. No calculated total score is available for the PETS 
(Eton et al., 2017).
Initial evidence of the reliability and validity of PETS has been 
demonstrated in large samples of chronically ill patient populations 
in the United States (Eton et al., 2017, 2019; Rogers et al., 2017). The 
Norwegian version of the PETS has shown satisfactory Cronbach's 
α, ranging from 0.71– 0.93 across the subscales (Husebø et al., 2021).
3.5  |  Sample size calculations
A sample size of 134 provides 84% statistical power to detect cor-
relations ≥0.25 using a two- tailed significance level of 0.05 (SPSS 
Sample Power 3.0). This sample size also allows for multivariable 
analysis within the rule of thumb of N ≥ 50 + 8 * IV (number of inde-
pendent variables; VanVoorhis & Morgan, 2007).
3.6  |  Data analysis
Study variables are described by frequency and percentage and by 
the median and interquartile range. Non- normally distributed data 
were revealed by applying the Kolmogorov– Smirnov test, and the 
non- parametric Mann– Whitney U and Kruskal– Wallis tests were 
used to explore differences in fatigue between groups. Spearman's 
rank correlation coefficient (rho; ρ) was used to assess the relation 
between fatigue and treatment burden, with and without controlling 
for confounding variables (age group, gender, cancer stage, treat-
ment modality, the time elapsed since primary surgery and number 
of comorbid conditions). The confounding variables were deter-
mined a priori (Babyak, 2004).
Stratified analyses were performed for the statistically signifi-
cant associations between CRF and PETS workload dimensions to 
assess possible moderating effects of socio- demographic and clin-
ical variables. In these analyses, we controlled for all confounders 
except the stratifying variable.
The strength of Spearman correlations was evaluated according 
to Cohen's guidelines, that is, correlations of 0.10– 0.29 represent-
ing small correlations, 0.30– 0.49 representing medium correlations 
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and 0.50 and above representing large correlations (Ivarsson et al., 
2013).
Data were analysed using SPSS version 25 (IBM Corp. Released, 
2017), except the estimation of partial correlations was accom-
plished with the R package PResiduals (R Foundation for Statistical 
Computing; R Core Team, 2013). Missing values on subscales were 
handled by imputing with the mean of the remaining items in cases 
where <50% of the items were missing. Three cases were missing 
for the SCFS- 6. For PETS, out of a total of 134 cases, missing cases 
varied from 0– 31 among the subscales (MINF = 31, MEDS = 12, 
MAP = 2, MH = 0, RLO = 5, MEXP = 12, HCS = 30, RAL = 10 and 
PMF = 3). Two- sided tests were applied, and p values <.05 were 
considered statistically significant for all analyses. Analytical meth-
ods taking account of the two different sampling strategies were not 
applied.
4  |  RESULTS
Of 166 eligible cancer survivors, 134 returned the written con-
sent and the survey inventory, resulting in a response rate of 84%. 
Reasons for non- participation were not collected. Participant char-
acteristics are presented in Table 1. Of the participants enrolled in 
the study, 62% were men, and the median age was 67 (range: 40– 
78 years). Forty- six per cent were surgically treated <6 months prior 
to taking part in the study. Regarding the cancer diagnosis, 71% were 
diagnosed with Dukes cancer Stage B or C. Adjuvant systemic treat-
ment (i.e., chemotherapy) was employed in 21% of the participants. 
Nearly 75% had two or more documented comorbidities in the pa-
tient records, and of those, 44% had two or more chronic conditions 
in addition to cancer. The results for treatment burden dimensions in 
this study population have been reported elsewhere (Husebø et al., 
2021).
4.1  |  CRF and associations with demographic and 
clinical variables
Total CRF, physical fatigue and perceptual fatigue in relation to the 
clinical variables of the CRC patient sample are presented in Table 2. 
The median CRF score in the included 131 patients treated for CRC 
was 10 (range: 6– 25). Patients between 40– 59 years of age reported 
higher fatigue levels than patients between 60– 79 years of age 
(p = .021). Patients with Dukes Stage C experienced more fatigue 
compared with those with Dukes A and B (p = .014). Gender, treat-
ment modality, the number of comorbid conditions and time elapsed 
since primary surgery were not significantly associated with total 
CRF.
Comparing physical and perceptual fatigue, the scores were 
highest for the subscale physical fatigue, with a median score of 
6.0 vs. 4.0 for the perceptual subscale. Younger patients reported 
significantly higher perceptual fatigue levels than older patients 
(median score of 4.5 vs. 3.0, p = .001). Both fatigue subscales were 
significantly associated with cancer stage, indicating that a more se-
vere cancer diagnosis (i.e., Dukes C) resulted in more physical (me-
dian score 7.0 vs. 5.0, p = .028) and perceptual (median score 5.0 vs. 
3.0, p = .011) fatigue. Perceptual fatigue was significantly associated 
with treatment modality (median score 5.0 vs. 3.0, p = .049), show-
ing that adjuvant treatment resulted in significantly higher levels of 
perceptual fatigue (Table 2). Gender, treatment modality, number of 
comorbidities and time elapsed since primary surgery were not sig-
nificantly associated with physical or perceptual fatigue.
4.2  |  Associations between CRF and treatment 
burden dimensions
The relationship between CRF (i.e., total, physical and perceptual) 
and the treatment burden was investigated using Spearman's ρ cor-
relation coefficients (Table 3). CRF was significantly associated with 
treatment burden on all PETS dimensions, except for the dimension 
MEDS. All significant correlations were positive, indicating that pa-
tients who experienced higher fatigue levels also reported higher 
levels of treatment burden. Correlations were small to medium for 
PETS dimensions pertaining to workload and stressors and medium 
to large for dimensions pertaining to impact of burden. There were 
consistently higher correlations between the PETS domains and 
perceptual fatigue than between the PETS domains and physical 
fatigue.
TA B L E  1  Demographic and clinical characteristics of the 
participants
Characteristic (N = 134)
Frequency 
(%)
Age group 40– 59 66 (49.3)
60– 79 68 (50.7)
Gender Male 83 (61.9)
Female 51 (38.1)
Time since primary surgical 
treatment
<6 months 62 (46.3)
6– 12 months 41 (30.6)
>12 months 31 (23.1)
Dukes cancer stage A 39 (29.1)
B 46 (34.3)
C 49 (36.6)
Treatment modality Neoadjuvant 14 (10.4)
Adjuvant 28 (20.9)
Surgery only 92 (68.7)
Comorbidity Yes 100 (74.6)
No 34 (25.4)
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There were only minor differences between the unadjusted and 
adjusted analyses. Significant unadjusted associations between the 
treatment burden dimensions and total CRF and the CRF subscales 
remained significant after adjusting for the following independent 
variables: age group, gender, Dukes cancer stage, treatment modality, 
the time elapsed since primary surgery and number of comorbid con-
ditions. The most considerable effect of adjusting was found for the 
association between total fatigue and the PETS domain MINF, and in 
particular for perceptual fatigue, with an increase in ρ from 0.34– 0.43 
after adjustment. Age group and treatment modality had the strongest 
confounding effect on the association between MINF and CRF.
4.3  |  Associations between CRF and treatment 
burden workload domains moderated by socio- 
demographic and clinical variables
Stratified analyses assessing moderation from socio- demographic 
and clinical variables of the association between CRF and three 
treatment burden workload domains (i.e., MINF, MAP and MH) are 
presented in Table 4. It showed that age moderated the association 
between CRF and all three dimensions, with higher correlations 
among patients <60 years than for patients 60– 79 years of age: par-
tial ρ.49 (p ≤ .001) vs. 0.32 (p = .037) for MINF, 0.36 (p = .007) vs. 









pMedian (IQR) Median (IQR) Median (IQR)
Total sample 131 10.0 (6.0– 25.0) — 132 6.0 (3.0– 13.0) — 131 4.0 (3.0– 12.0) — 
Age group .021 .089 .001
40– 59 years 66 11.0 (7.8– 16.0) 66 6.0 (4.0– 8.3) 66 4.5 (3.0– 7.0)
60– 79 years 65 8.0 (7.0– 12.0) 66 5.0 (4.0– 7.0) 65 3.0 (3.0– 5.0)
Gender .65 .90 .31
Male 81 9.0 (7.0– 13.0) 81 6.0 (4.0– 8.0) 80 4.0 (3.0– 5.5.0)




Dukes A 38 8.0 (7.0– 12.0) 38 5.0 (4.0– 7.3) 38 3.0 (3.0– 5.0)
Dukes B 45 9.0 (6.0– 12.0) 46 5.0 (4.0– 7.3) 45 3.0 (3.0– 5.0)




Surgery only 89 9.0 (6.0– 25.0) 89 5.0 (4.0– 6.5) 89 3.0 (3.0– 5.0)
Neoadjuvant 14 10.0 (7.0– 13.3) 14 6.0 (3.0– 9.0) 14 4.0 (3.0– 5.3)





0 condition 41 12.0 (8.0– 15.5) 41 6.0 (4.0– 8.5) 41 5.0 (3.0– 7.0)
1 condition 35 8.0 (6.0– 11.0) 35 5.0 (3.0– 6.0) 35 3.0 (3.0– 5.0)
2 conditions 30 9.5 (7.0– 13.5) 31 6.0 (4.0– 8.0) 30 3.5 (3.0– 5.0)






<6 months 61 10.0 (8.0– 13.0) 61 6.0 (4.3– 8.0) 61 4.0 (3.0– 5.0)
6– 12 months 40 9.5 (7.3– 16.0) 40 6.0 (4.0– 8.8) 40 4.0 (3.0– 6.8)
12– 18 months 30 8.0 (6.0– 13.0) 31 5.0 (3.0– 8.0) 30 3.0 (3.0– 6.0)
Abbreviations: CRF, cancer- related fatigue; IQR, interquartile range.
aCRF measured by the Schwartz Cancer Fatigue Scale- 6 (total score range: 6– 30).
bSchwartz Cancer Fatigue Scale- 6 Physical subscale (score range: 3– 15).
cSchwartz Cancer Fatigue Scale- 6 Perceptual subscale (score range: 3– 15).
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0.00 (p = .098) for MAP and 0.50 (p = .005) vs. 0.17 (p = .31) for 
MH. Correlations were also consistently higher among women than 
among men. Those with no additional treatment had higher correla-
tions between CRF and MINF and MH but not MAP. Longer time 
since primary surgery resulted in higher correlations between CRF 
and MINF. Patients with less comorbidities (0 or 1 chronic disease) 
had higher correlations between CRF and MAP, whereas those with 
1 or 2 chronic diseases had higher correlations between CRF and 
MH.
5  |  DISCUSSION
This study measured the levels of CRF in a sample of CRC patients 
surgically treated with curative intent, how the CRF level varied giv-
ing demographic and clinical variables, and explored the associations 
between CRF and treatment burden.
5.1  |  CRF in surgically treated CRC patients
In line with earlier research, our findings confirmed that CRF is el-
evated among CRC patients following surgical treatment (Thong 
et al., 2013, 2020). Although the average CRF level of this study 
population equated to scores on the lower third of the scale, CRF 
was reported as a problem. The result compares to earlier research 
on CRF in Norwegian surgically treated cancer populations using 
SCFS- 6, where women with breast cancer reported SCFS- 6 levels 
between 10.3 (SD: ±3.9) and 11.3 (±4.5; Husebø et al., 2014). An 
exercise trial among American prostate cancer survivors who were 
on average 6 years past diagnosis found similar baseline SCFS- 6 lev-
els of 9.2 (±3.0) to 9.9 (±4.5; Winters- Stone et al., 2015), whereas 
a study among Canadian lung cancer patients found slightly more 
elevated SCFS- 6 of 12.3 (±4.4) pre- chemotherapy (Shallwani et al., 
2016). Notably, in the current study, nearly 70% of the sample had 
received surgical treatment <6 months before responding to the 
survey, and nearly one third had received adjuvant chemotherapy.
In this study, physical fatigue was found to be more prominent 
than perceptual fatigue among the included patients, indicating an 
impact on physical functioning (Schwartz et al., 2003). Older CRC 
patients (≥70 years) are at particular risk of impaired physical func-
tion after surgery, and it may take months before a patient achieves 
pre- surgical functional status (Couwenberg et al., 2018). To improve 
post- surgical patient outcomes, it is now recommended a CRC pa-
tient's available pre- surgical capacity is considered by screening 
those at risk of declined physical functioning (Ghignone et al., 2020).
A statistically significant age difference was observed for CRF, 
with younger CRC patients reporting more fatigue than older pa-
tients. This confirms findings from a large longitudinal study of CRC 
survivors that established significant associations between fatigue 
symptoms and patients who were pre- retirement (≤65 years of age; 
Husson et al., 2015). Fatigue subscale analysis revealed that younger 
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thinking and feeling overwhelmed and helpless (Schwartz & Meek, 
1999). This may be explained by younger CRC patients undergoing 
more extensive post- surgery treatment, including chemotherapy 
(Kneuertz et al., 2015). Furthermore, younger CRC patients may 
have more occupational and family responsibilities than older pa-
tients, which can potentially increase fatigue. Including the patient's 
nearest family and provide them with information adapted to the 
recipient's age and family role is a concern of nurses who care for 
CRC surgery patients (Husebø et al., 2020). Moreover, it is recom-
mended to employ PROMs that include employment and caring for 
dependants when assessing cancer patients' social well- being (Catt 
et al., 2017).
We also found that patients with more advanced cancer and 
who had received adjuvant treatments appeared more fatigued, es-
pecially on the perceptual fatigue subscale. Nurses play an essential 
role in helping cancer patients manage their fatigue during chemo-
therapy treatment (Lavdaniti, 2019). Our findings suggest that nurs-
ing interventions are needed that regularly enquire about a CRC 
patient's fatigue experience during treatment. This should take into 
account the possibility that a patient's cognition may be impaired 
when information is delivered. Moreover, a meta- analysis showed 
significant effects from eHealth and mHealth interventions on CRF 
among cancer survivors, with interventions guided by health profes-
sionals proving to be the most effective (Seiler et al., 2017).
The CRF levels were slightly, though not significantly, lower 
among patients with a longer time since surgery. The lack of signifi-
cance could be due to low statistical power. The slight tendency for 
lower CRF with time from surgery is somewhat in line with a recent 
meta- analysis among rectal cancer patients, which found substantial 
changes in CRF through the course of the illness, with CRF levels 
declining gradually over the 12 months following diagnosis (Wen- 
Pei & Hsiu- Ju, 2020). Future research should include a longitudinal 
study design to detect changes over time in the fatigue experience 
of CRC patients.
5.2  |  The relationship between CRF and treatment 
burden in patients curatively treated for CRC
In this study, most of the treatment burden dimensions were signifi-
cantly associated with CRF and the associations held after adjusting 
for demographic and clinical variables. Our findings also identified 
subgroups of CRC patients with CRF being particularly strongly as-
sociated with burden from finding and using medical information, 
administrating and follow- up on medical appointments and monitor-
ing their health. These subgroups are in need of special attention 
and support to keep themselves sufficiently informed, to cope with 
a busy schedule as a patient and to register change in their health 
condition and symptoms of exacerbation or cancer recurrence.
Overall, the associations with treatment burden were more 
substantial for the perceptual fatigue dimension than for the phys-
ical dimension. Among the generic self- management tasks related 
to CRC treatment that were associated with CRF were retrieving 
relevant health information and gaining knowledge about the ill-
ness and its treatments (i.e., PETS dimension MINF). We found 
that this task was associated with the patients' degree of percep-
tual fatigue and that the type of treatment a patient received had 
a confounding effect on this association. A previous study by our 
group revealed a non- significant association between the PETS 
domain MINF and treatment modality in the current sample of CRC 
patients (Husebø et al., 2021), which might indicate that suffering 
from CRF increases the workload associated with finding and un-
derstanding medical information in patients who receive adjuvant 
treatments. Adjuvant therapies have a toxic impact on the brain 
and can cause memory loss and cognitive deficiencies (El- Agamy 
et al., 2019), and they are associated with fatigue (Dhillon et al., 
2018). Thus, CRC patients who receive chemotherapy may find 
it harder to engage in information seeking due to the impaired 
cognitive ability from CRF. Nurses are encouraged to provide pa-
tients with education and information on interventions to amelio-
rate fatigue (Lavdaniti, 2019). Moreover, measures to counteract 
the fatigue experience, such as physical activity approaches, hold 
the potential to increase cancer patients' chemotherapy tolerance 
(Hilfiker et al., 2018). Interestingly, Anderson et al. (2021) identi-
fied the impact from self- management (i.e., PETS dimensions RAL 
and PMF) as a mediator of effects from health literacy on cancer 
survivors' general health. Psycho- educational group- based nurs-
ing interventions, including cognitive– behavioural techniques and 
patient education, are suggested to decrease the CRF in cancer 
patients (Tuominen et al., 2019). In particular, comorbid cancer 
survivors may face multiple cancers and more general challenges; 
thus, cancer support programmes may evaluate the totality of self- 
management (Anderson et al., 2021).
The successful self- management of long- term illness requires 
patients to obtain information from various sources and possess a 
high degree of health literacy (i.e., the ability to find, understand 
and use health information), which may increase self- efficacy re-
garding self- management skills (Mackey et al., 2016). A randomised 
controlled trial that investigated the effects of a patient information 
letter at hospital discharge found significantly increased treatment 
comprehension and health literacy in the intervention group com-
pared with control (Voigt et al., 2018). Jones et al. (2016) suggested 
that a process of individualised care planning might enable cancer 
patients who experience CRF to set achievable goals and could pro-
vide them with education to promote self- management strategies. 
By identifying the burden associated with self- management tasks of 
information finding, nurses are in a position to strengthen patient 
participation in treatment- related discussions and shared decision- 
making (Rogers et al., 2017).
The largest correlation was found for the PETS dimensions of 
physical and mental fatigue, representing the impact of treatment 
burden (Lee et al., 2020). Anderson et al. (2021) established negative 
effects from self- management on general health outcomes including 
fatigue in women with cancer. The direction of the relationship be-
tween the impact from treatment burden and CRF needs to be fur-
ther explored, that is, whether treatment burden leads to more CRF 
10  |    HUSEBØ Et al.
or whether being fatigued from cancer and its treatments affects a 
CRC patient's ability to deal with the work of CRC self- management.
Further, it is evident that experiencing worsening psychosocial 
function owing to CRC self- management (i.e., PETS dimension RAL) 
is significantly associated with CRF. Foster et al. (2015) suggested 
supporting cancer patients in building their confidence to better 
self- manage the consequences of cancer diagnosis and treatments, 
including CRF. Feasible and efficient web- based approaches may 
provide cancer survivors with safe and necessary CRF management 
tools (Myall et al., 2015). We found no statistically significant as-
sociations between treatment burden from managing medications 
(e.g., taking medicines as planned, refilling and adjusting medicines 
and multiple medicines; i.e., PETS dimension MEDS) and CRF. This 
may be explained by a low number of participants responding to the 
MEDS items, indicating that medication burden was experienced as 
low in relation to the cancer diagnosis.
There seem to be a particularly strong association between CRF 
and the burden from finding relevant medical information and from 
monitoring health among CRC patients who receive surgical treat-
ment only. This may indicate a higher information need and uncer-
tainty towards monitoring their health in CRC survivors with a less 
advanced cancer diagnosis. According to treatment plans, they will 
have less contact with specialist cancer care services compared with 
patients who stay longer in the healthcare system due to the need 
of adjuvant treatments and who may get information needs covered 
and health condition monitored by outpatient clinic personnel. This 
finding is in contrast with a study among Dutch CRC survivors, show-
ing that survivors who received chemotherapy expressed a greater 
need for sustained informational support (Wieldraaijer et al., 2019). 
Our study suggests self- management support for CRC patients with 
less advanced cancer and no additional treatment following surgery 
who experience CRF to increase knowledge of what to expect during 
recovery and what and how to monitor health condition change.
In our 2020 paper on treatment burden in the same sample of 
CRC patients, no significant correlations were found between co-
morbidity and treatment burden (Husebø et al., 2020). However, 
the current study confirms that comorbidity in CRC patients with 
CRF may complicate self- management tasks of monitoring health, 
indicating that the presence of CRF increases the burden from mon-
itoring health.
5.3  |  Limitations
There were some limitations to this study. The cross- sectional design 
may limit understanding of the concept of treatment burden in CRC 
patients. Furthermore, the study was performed in one university 
hospital in Norway; therefore, the results might not be generalisable 
to other geographic regions. However, the governmental cancer care 
set- up in a national context serves as a strong guide, and our obser-
vations would likely be similar to those obtained from other regions.
The sample size may be considered small, but it was large enough 
to show significant correlations between CRF and treatment burden. 
Moreover, the relationship between CRF and treatment burden may 
be affected by other confounding variables, such as the patient's de-
pression level. It can be challenging to separate fatigue from depres-
sion, and both can compromise the daily life functioning of cancer 
patients (Wen- Pei & Hsiu- Ju, 2020).
Analytical methods to determine differences between groups 
created by different recruitment procedures were not undertaken 
and should be considered a weakness of the study design.
The Norwegian version of the PETS has yet to be tested for 
psychometric properties beyond establishing satisfactory levels of 
reliability. Furthermore, the original version of the PETS was devel-
oped and validated in multimorbid patient populations (Eton et al., 
2017) and is not condition or diagnosis specific. The majority of the 
respondents of the current study reported having one other chronic 
condition comorbid to CRC. Thus, the burden these CRC patients 
experienced may also result from self- management of other chronic 
conditions.
Further research is warranted to establish the PETS' ability to 
capture the treatment burden of CRC patients. For two of the PETS 
dimensions (MINF and HCS), there were considerably more missing 
cases than for the other dimensions. This can be explained by the 
availability of ‘does not apply to me’ as a response, which was re-
corded as ‘missing’ during scoring (Eton et al., 2017).
This study included both self- reported and observational data 
from a single cancer type, which may be considered a strength com-
pared with earlier research that included a range of different cancer 
patient populations.
6  |  CONCLUSION
The study found that younger CRC patients, those with a more ad-
vanced cancer stage and those offered adjuvant treatments were 
at particular risk of CRF. CRF was significantly associated with sev-
eral treatment burden dimensions, indicating that CRC patients 
who experience CRF will also likely experience burden from cancer 
therapies and self- management. The patient workload of finding and 
understanding medical information relevant to self- management 
of the cancer illness and treatments was particularly associated 
with perceptual fatigue, but this relationship was confounded by 
the patient's age and the treatment received. Moreover, CRC self- 
management's impact on the patient's well- being was strongly and 
significantly associated with CRF. CRC patient subgroups of younger 
age, no additional treatment, longer time since primary surgery and 
multimorbidity showed higher correlations between CRF and treat-
ment burden.
7  |  IMPLIC ATIONS FOR PR AC TICE
This study suggests that clinicians should pay particular attention 
to the fatigue experience of CRC patients who are younger of age 
and those with more advanced disease undergoing treatments in 
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addition to primary, surgical procedures. Considering the short 
inpatient stays of people undergoing primary surgery, it can be 
challenging for clinicians to capture and meet patients' need for self- 
management support. Thus, screening patients for self- management 
ability and treatment burden should be considered for incorporation 
into the clinical pathway. Support following hospital discharge could 
also be extended by providing nurse- led eHealth interventions, with 
a focus on informational, educational and psychosocial support to 
strengthen the capacity for self- management and ameliorate CRF. 
Such interventions may especially be appropriate for younger CRC 
survivors, CRC survivors with advanced cancer, longer time since 
primary surgery or for comorbid CRC survivors.
8  |  RELE VANCE TO CLINIC AL PR AC TICE
Screening of CRF in CRC patients can help clinicians provide indi-
vidualised treatment and care to manage CRF. Clinicians should con-
sider the association between CRF and treatment burden, especially 
in subgroups of CRF patients.
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